Sympathetic innervation of the kidney in health and disease

Handbook of the Autonomic Nervous System in Health and Disease

Volumn , Issue , 2002, Pages 561-587

  Rump, Lars Christian ^a   Amann, Kerstin ^b   Ritz, Eberhard ^c  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84869506615     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (148)

1. DiBona GF, Kopp UC. Neural control of renal function. Physiol Rev 1997; 77:75-197.
2. Barajas L, Liu L, Powers K. Anatomy of the renal innervation: intrarenal aspects and ganglia of origin. Can J Physiol Pharmacol 1992; 70:735-749.
3. Gattone VH, Marfurt CF, Dallie S. Extrinsic innervation of the rat kidney: a retrograde tracing study. Am J Physiol 1986; 250(2 Pt 2):F189-196.
4. Schramm LP, Strack AM, Platt KB, Loewy AD. Peripheral and central pathways regulating the kidney: a study using pseudorabies virus. Brain Res 1993; 616:251-262.
5. Dibona GF. Renal dopamine containing nerves. What is their functional significance? Am J Hypertens 1990; 3:64S-67S.
6. Rump LC, Schwertfeger E, Schuster MJ, Schaible U, Frankenschmidt A, Schollmeyer PJ. Dopamine DA2-receptor activation inhibits norepinephrine release in human kidney slices. Kidney Int 1993; 43:197-204.
7. McKenna OC, Angelakos ET. Adrenergic innervation of the canine kidney. Circ Res 1968; 22:345-354.
8. Dieterich HJ. Electron microscopic studies of the innervation of the rat kidney. Z Anat Entwicklungsgesch 1974; 145:169-186.
9. Barajas L, Powers K, Wang P. Innervation of the renal cortical tubules: a quantitative study. Am J Physiol 1984; 247(1 Pt 2):F50-60.
10. Schwartz DD, Malik KU. Renal periarterial nerve stimulation-induced vasoconstriction at low frequencies is primarily due to release of a purinergic transmitter in the rat. J Pharmacol Exp Ther 1989; 250:764-771.
11. 2 inhibits noradrenaline release and purinergic pressor responses to renal nerve stimulation at 1 Hz in isolated kidneys of young spontaneously hypertensive rats. J Hypertens 1990; 8:897-908.
12. Bohmann C, Rump LC, Schaible U, von Kügelgen. α-Adrenoceptor modulation of norepinephrine and ATP release in isolated kidneys of spontaneously hypertensive rats. Hypertension 1995; 25:1224-1231.
13. Rump LC, Bohmann C, Schwertfeger E, Krumme B, Von Kügelgen I, Schollmeyer P. Extracellular ATP in the human kidney: Mode of release and vascular effects. J Auton Pharmacol 1996; 16:371-376.
14. Oberhauser V, Vonend O, Rump LC. Neuropeptide Y and ATP interact to control renovascular resistance in the rat. J Am Soc Nephrol 1999; 10:1179-1185.
15. 2, NPY and angiotensin II receptors. Naunyn-Schmiedebergs Arch Pharmacol 1989; 340:379-385.
16. Bylund DB, Eikenberg DC, Hieble JP, Langer SZ, Lefkowitz RJ, Minneman KP, Molinoff PB, Ruffolo RR Jr, Trendelenburg U. International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol Rev 1994; 46:121-136.
17. 2D-Adrenoceptors modulate renal norepinephrine release in normotensive and spontaneously hypertensive rats. Eur J Pharmacol 1995; 217:283-292.
18. 2C-adrenergic receptors mediate inhibition of norepinephrine release in human kidney cortex. Mol Pharmacol 1994; 45:1168-1176.
19. 2-autoreceptors: rat vena cava, rat atria, human kidney and guinea-pig urethra. Naunyn-Schmiedeberg’s Arch Pharmacol 1997; 356:721-737.
20. Trendelenburg AU, Hein L, Gaiser EG, Starke K. Occurrence, pharmacology and function of presynaptic alpha2-autoreceptors in alpha2A/D-adrenoceptor-deficient mice. Naunyn Schmiedebergs Arch Pharmacol 1999; 360:540-515.
21. 3H]-nora-drenaline release and vascular tone in rat isolated kidney. Br J Pharmacol 1989; 97:819-828.
22. 2-adrenoceptors in rat isolated kidney: involvement of purines and prostaglandins. Naunyn-Schmiedeberg’s Arch Pharmacol 1993; 347:273-279.
23. Bohmann C, Von Kugelgen I, Rump LC. P2-Purinoceptor modulation of rat renal neurotransmission. Br J Pharmacol 1997; 121:1255-1262.
24. Rump LC, Riess M, Schwertfeger E, Michel MC, Bohmann C, Schollmeyer P. Prejunctional neuropeptid Y receptors in human kidney and atrium. J Cardiovasc Pharmacol 1997; 29:656-661.
25. Rump LC, Bohmann C, Schaible U, Schultze-Seemann W, Schollmeyer PJ. P-Adrenergic, angiotensin II, and bradykinin receptors enhance neurotransmission in human kidney. Hypertension 1995; 26:445-451.
26. Michel MC, Rump LC. Alpha-adrenergic regulation of human renal function. Fun-dam Clin Pharmacol 1996; 10:493-503.
27. Wolff DW, Gesek FA, Strandhoy JW. In vivo assessment of rat renal alpha adrenoceptors. J Pharmacol Exp Ther 1987; 241:472-476.
28. Strandhoy JW, Wolff DW, Buckalew VM Jr. Renal alpha 1- and alpha 2-adrenoceptor mediated vasoconstriction in dogs. J Hypertens Suppl 1984; 2:S151-S153.
29. Hesse IFA, Johns EJ. An in vivo study of the alpha-adrenoreceptor subtypes on the renal vasculature of the anaesthetized rabbit. J Auton Pharmacol 1984; 4:145-152.
30. 2-adrenoceptors in isolated perfused kidneys of spontaneously hypertensive rats. Cardiovasc Res 1995; 30:857-865.
31. De Leeuw PW, van Es PN, de Bos R, Birkenhager WH. Role of alpha 1- and alpha 2-adrenergic receptors in the human hypertensive kidney. Hypertension 1987; 9(6 Pt 2):210-212.
32. 2-Adrenoceptor activation inhibits noradrenaline release in human and rabbit renal arteries. Eur J Pharmacol 1991; 196:277-283.
33. Nakamura KT, Alden BM, Matheme GP, Jose PA, Robillard JE. Ontogeny of renal hemodynamic response to terbutaline and forskolin in sheep. J Pharmacol Exp Ther 1988; 247:453-459.
34. Baines AD, Drangova R, Ho P. Neural stimulation of gluconeogenesis in isolated pyruvate-perfused rat kidneys. Can J Physiol Pharmacol. 1988; 66:106-111.
35. Cooper CL, Malik KU. Prostaglandin synthesis and renal vasoconstriction elicited by adrenergic stimuli are linked toactivation of alpha-1 adrenergic receptors in the isolated rat kidney. J Pharmacol Exp Ther 1985; 233:24-31.
36. Satoh C, Satoh F, Takahashi K, Murakami O, Sone M, Totsune K, Yabe T, Ohneda M, Fukuda M, Sugimura K, Ogawa S, Nagakubo H, Sato T, Mouri T. Elevated plasma immunoreactive neuropeptide Y concentrations and its increased urinary excretion in patients with advanced diabetic nephropathy. Endocr J 1999; 46:139-146.
37. Bald M, Gerigk M, Rascher W. Elevated plasma concentrations of neuropeptide Y in children and adults with chronic and terminal renal failure. Am J Kidney Dis 1997; 30:23-27.
38. Kokot F, Adamczak M, Wiecedilcek A, Spiechowicz U, Mesjasz J. Plasma im-munoreactive leptin and neuropeptide Y levels in kidney transplant patients. Am J Nephrol 1999; 19:28-33.
39. 2X-agonist α,β-methylene ATP in human cutaneous and renal blood vessels. Br J Pharmacol 1995; 116:1932-1936.
40. Rump LC, Oberhauser V, von Kügelgen I. Purinoceptors mediate renal vasodilation by nitric oxide dependent and independent mechanisms. Kidney Int 1998; 54:473-481.
41. Churchill PC, Ellis VR. Purinergic P2y receptors stimulate renin secretion by rat renal cortical slices. J Pharmacol Exp Ther 1993; 266:160-163.
42. Van Der Weyden L, Adams DJ, Morris BJ. Capacity for purinergic control of renin promoter via P2Y(11) receptor and cAMP pathways. Hypertension 2000; 36:1093-1098.
43. Cha SH, Jung KY, Endou H. Effect of P2Y-purinoceptor stimulation on renal glu-coneogenesis in rats. Biochem Biophys Res Commun. 1995; 211:454-461.
44. Wolf G, Helmchen U, Stahl RA. Isoproterenol stimulates tubular DNA replication in mice. Nephrol Dial Transplant 1996; 11:2288-2292.
45. Kribben A, Herget-Rosenthal S, Lange B, Michel MC, Philipp T. Stimulation of mitogen activated protein kinase and cellular proliferation in renal proximal tubular cells. Ren Fail 1998; 20:229-234.
46. Nie M, Selbie LA. Neuropeptide Y Y1 and Y2 receptor-mediated stimulation of mitogen-activated protein kinase activity. Reg Pept 1998; 75-76:207-213.
47. Pellieux C, Sauthier T, Domenighetti A, Marsh DJ, Palmiter RD, Brunner HR, Pe-drazzini T. Neuropeptide Y (NPY) potentiates phenylephrine-induced mitogen-activated protein kinase activation in primary cardiomyocytes via NPY Y5 receptors. Proc Natl Acad Sci 2000; 97:1595-1600.
48. Rump LC, Le Talec T, Oberhauser V. Sympathetic neurotransmitters ATP, neuropeptide and norepinephrine induce proliferation of human visceral glomerular epithelial cells. Hypertension 1999; 34:711.
49. Erlinge D. Extracellular ATP: a growth factor for vascular smooth muscle cells. Gen Pharmacol 1998; 31:1-8.
50. Schulze-Lohoff E, Ogilvie A, Sterzel RB. Extracellular nucleotides as signalling molecules for renal mesangial cells. J Auton Pharmacol 1996; 16:381-384.
51. Harada H, Chan CM, Loesch A, Unwin R, Burnstock G. Induction of proliferation and apoptotic cell death via P2Y and P2X receptors, respectively, in rat glomerular mesangial cells. Kidney Int 2000; 57:949-958.
52. Rump LC, Amann K, Orth S, Ritz E. Sympathetic overactivity in renal disease: a window to understand progression and cardiovascular complications of uraemia? Nephrol Dial Transplant 2000; 11:1735-1738.
53. Rump LC. Invited comment: advantages of Ang II receptor blockade over ACE inhibition with respect to suppression of sympathetic activity: heartening news for the kidney? Nephrol Dial Transplant 1999; 14:556-559.
54. Marfurt CF, Echtenkamp SF. Sensory innervation of the rat kidney and ureter as revealed by the anterograde transport of wheat germ agglutinin-horseradish peroxidase (WGA-HRP) from dorsal root ganglia. J Comp Neurol 1991; 311:389-404.
55. Su HC, Wharton J, Polak JM, Mulderry PK, Ghatei MA, Gibson SJ, Terenghi G, Morrison JF, Ballesta J, Bloom SR. Calcitonin gene-related peptide immunoreac-tivity in afferent neurons supplying the urinary tract: combined retrograde tracing and immunohistochemistry. Neuroscience 1986; 18:727-747.
56. Ciriello J, Calaresu FR. Central projections of afferent renal fibers in the rat: an anterograde transport study of horseradish peroxidase. J Auton Nerv Syst 1983; 8:273-285.
57. Ciriello J, Calaresu FR. Hypothalamic projections of renal afferent nerves in the cat. Can J Physiol Pharmacol 1980; 58:574-576.
58. Barajas L, Liu L, Nishiyama C. Prenatal and postnatal development of the CGRP-immunoreactive innervation in the rat kidney. Neurosci Lett 1991; 133:219-224.
59. Knight DS, Cicero S, Beal JA. Calcitonin gene-related peptide-immunoreactive nerves in the rat kidney. Am J Anat 1991; 190:31-40.
60. Colindres RE, Spielman WS, Moss NG, Harrington WW, Gottschalk CW. Functional evidence for renorenal reflexes in the rat. Am J Physiol 1980; 239(3):F265-270.
61. Ye S, Gamburd M, Mozayeni P, Koss M, Campese VM. A limited renal injury may cause a permanent form of neurogenic hypertension. Am J Hypertens 1998; 11(6 Pt 1):723-728.
62. Campese VM, Kogosov E. Renal afferent denervation prevents hypertension in rats with chronic renal failure. Hypertension 1995; 25:878-882.
63. Katholi RE, Whitlow PL, Hageman GR. Intrarenal adenosine produces hypertension by activating the sympathetic nervous system via the renal nerves in the dog. J Hypertens 1984; 2:349-359.
64. Zhang W, Li JL, Hosaka M, Janz R, Shelton JM, Albright GM, Richardson JA, Sudhof TC, Victor RG. Cyclosporine A-induced hypertension involves synapsin in renal sensory nerve endings. Proc Natl Acad Sci 2000; 97:9765-9770.
65. Wagner C, Hinder M, Kramer BK, Kurtz A. Role of renal nerves in the stimulation of the renin system by reduced renal arterial pressure. Hypertension 1999; 34:1101-1105.
66. Linas SL, Miller PD, McDonald KM, Stables DP, Katz F, Weil R, Schrier RW. Role of the renin-angiotensin system in post-transplantation hypertension in patients with multiple kidneys. N Engl J Med 1978; 298:1440-1444.
67. DiBona GF. The functions of the renal nerves. Rev Physiol Pharmacol Biochem Pharmacol 1982; 94:76-181.
68. Kirchheim H. Regulation of renal hemodynamics in congestive heart failure. In: Just H, Bussmann WD, eds. Vasodilators in Chronic Heart Failure. New York: SpringerVerlag, 1983, 36-46.
69. Kirchheim H, Ehmke H, Persson P. Sympathetic modulation of renal hemodynamics, renin release and sodium excretion. Klin Wochenschr 1989; 67:858-864.
70. Ehmke H, Persson P, Fischer S, Hackenthal E, Kirchheim H. Resetting of pressure-dependent renin release by intrarenal alpha 1-adrenoceptors in conscious dogs. Pflugers Arch 1989; 413:261-266.
71. Gross R, Hackenberg HM, Hackenthal E, Kirchheim H. Interaction between perfusion pressure and sympathetic nerves in renin release by carotid baroreflex in conscious dogs. J Physiol 1981; 313:237-250.
72. Gross R, Kirchheim H. Effects of bilateral carotid and auditory stimulation on renal blood flow and sympathetic nerve activity in the conscious dog. Pflugers Arch 1980; 383:233-239.
73. Osborn JL, DiBona GF, Thames MD. Beta-1 receptor mediation of renin secretion elicited by low-frequency renal nerve stimulation. J Pharmacol Exp Ther 1981; 216:265-269.
74. Kopp U, Aurell M, Nilsson IM, Ablad B. The role of beta-1-adrenoceptors in the renin release response to graded renal sympathetic nerve stimulation. Pflugers Arch 1980; 387:107-113.
75. Kopp U, Aurell M, Sjolander M, Ablad B. The role of prostaglandins in the alpha-and beta-adrenoceptor mediated renin release response to graded renal nerve stimulation. Pflugers Arch 1981; 391:1-8.
76. Cohen HT, Takemoto F, Satoh T, Katz Al. Renal adrenergic receptors: localization of [125]prazosin binding sites along the microdissected rat nephron. Can J Physiol Pharmacol 1992; 70:1016-1020.
77. Holtback U, Ohtomo Y, Forberg P, Sahlgren B, Aperia A. Neuropeptide Y shifts equilibrium between alpha- and beta-adrenergic tonus in proximal tubule cells. Am J Physiol 1998; 275(1 Pt 2):F1-7.
78. Schmitz JM, Graham RM, Sagalowsky A, Pettinger WA. Renal alpha-1 and alpha-2 adrenergic receptors: biochemical and pharmacological correlations. J Pharmacol Exp Ther 1981; 219:400-406.
79. Wiborn TW, Sun D, Schafer JA. Expression of multiple alpha-adrenoceptor isoforms in rat CCD. Am J Physiol 1998; 275(1 Pt 2):F111-118.
80. Rettig R, Bandelow N, Patschan O, Kuttler B, Frey B, Uber A. The importance of the kidney in primary hypertension: insights from cross-transplantation. J Hum Hypertens 1996; 10:641-644.
81. Curtis JJ, Luke RG, Dustan HP, Kashgarian M, Whelchel JD, Jones P, Diethelm AG. Remission of essential hypertension after renal transplantation. N Engl J Med 1983; 309:1009-1015.
82. Grisk O, Rose HJ, Rettig R. The development of post-transplantation hypertension in recipients of an SHR kidney is independent of reinnvervation of the graft. Pflugers Arch 1999; 438:502-507.
83. Katholi RE. Renal nerves in the pathogenesis of hypertension in experimental animals and humans. Am J Physiol 1983; 245:F1-14.
84. Roman RJ, Cowley AW Jr. Characterization of a new model for the study of pres-sure-natriuresis in the rat. Am J Physiol 1985; 248(2 Pt 2):F190-198.
85. Ehmke H, Persson PB, Seyfarth M, Kirchheim HR. Neurogenic control of pressure natriuresis in conscious dogs. Am J Physiol 1990; 259(3 Pt 2):F466-473.
86. Esler M, Jennings G, Lambert G. Noradrenaline release and the pathophysiology of primary human hypertension. Am J Hypertens 1989; 2(3 Pt 2):140S-146S.
87. Johansson M, Elam M, Rundqvist B, Eisenhofer G, Herlitz H, Lambert G, Friberg P. Increased sympathetic nerve activity in renovascular hypertension. Circulation 1999; 99:2537-2542.
88. Hollenberg NK, Adams DF, Solomon H, Chenitz WR, Burger BM, Abrams HL, Merrill JP. Renal vascular tone in essential and secondary hypertension: hemodynamic and responses to vasodilators. Medicine (Baltimore) 1975; 54:29-44.
89. Lorelius LE, Lofroth PO, Morlin C, Wiklund L, Aberg H. Renal haemodynamics before and after splanchnic block in patients with hypertension. Scand J Clin Lab Invest 1978; 38:233-240.
90. Liard JF. Renal denervation delays blood pressure increase in the spontaneously hypertensive rat. Experientia 1977; 33:339-340.
91. Saynavalammi P, Vaalasti A, Pyykonen ML, Ylitalo P, Vapaatalo H. The effect of renal sympathectomy on blood pressure and plasma renin activity in spontaneously hypertensive and normotensive rats. Acta Physiol Scand 1982; 115:289-293.
92. Winternitz SR, Katholi RE, Oparil S. Role of the renal sympathetic nerves in the development and maintenance of hypertension in the spontaneously hypertensive rat. J Clin Invest 1980; 66:971-978.
93. Nagaoka A, Kakihana M. Effects of renal sympathectomy on sodium and water excretion in stroke-prone spontaneously hypertensive rats. Jpn J Pharmacol 1982; 32:591-597.
94. Katholi RE, Winternitz SR, Oparil S. Decrease in peripheral sympathetic nervous system activity following renal denervation or unclipping in the one-kidney one-clip Goldblatt hypertensive rat. J Clin Invest 1982; 69:55-62.
95. Takahashi H, Iyoda I, Yamasaki H, Takeda K, Okajima H, Sasaki S, Yoshimura M, Nakagawa M, Ijichi H. Retardation of the development of hypertension in DOCA- salt rats by renal denervation. Jpn Circ J 1984; 48:567-574.
96. Kline RL, Denton KM, Anderson WP. Effect of renal denervation on the development of cellophane-wrap hypertension in rabbits. Clin Exp Hypertens A 1986; 3(8):1327-1342.
97. Kassab S, Kato T, Wilkins FC, Chen R, Hall JE, Granger JP. Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension 1995; 25:893-897.
98. Rumantir MS, Vaz M, Jennings GL, Collier G, Kaye DM, Seals DR, Wiesner GH, Brunner-La Rocca HP, Esler M. Neural mechanisms in human obesity-related hypertension. J Hypertens 1999; 17:1125-1133.
99. Lundin S, Ricksten SE, Thoren P. Renal sympathetic activity in spontaneously hypertensive rats and normotensive controls, as studied by three different methods. Acta Physiol Scand 1984; 120:265-272.
100. Collis MG, DeMey C, Vanhoutte PM. Renal vascular reactivity in the young spontaneously hypertensive rat. Hypertension 1980; 2:45-52.
101. Ekas RD Jr, Steenberg ML, Lokhandwala MF. Increased norepinephrine release during sympathetic nerve stimulation and its inhibition by adenosine in the isolated perfused kidney of spontaneously hypertensive rats. Clin Exp Hypertens A 1983; 5:41-48.
102. Yoshida M, Satoh S. Role of renal nerves on pressure natriuresis in spontaneously hypertensive rats. Am J Physiol 1991; 260(1 Pt 2):F81-85.
103. Janssen BJ, van Essen H, Vervoort-Peters LH, Struyker-Boudier HA, Smits JF. Role of afferent renal nerves in spontaneous hypertension in rats. Hypertension 1989; 13:327-333.
104. Huang WC, Fang TC, Cheng JT. Renal denervation prevents and reverses hyperin-sulinemia-induced hypertension in rats. Hypertension 1998; 32:249-254.
105. Wyss JM, Sripairojthikoon W, Oparil S. Failure of renal denervation to attenuate hypertension in Dahl NaCl-sensitive rats. Can J Physiol Pharmacol 1987; 65:2428-2432.
106. Granger J, Novak J, Schnackenberg C, Williams S, Reinhart GA. Role of renal nerves in mediating the hypertensive effects of nitric oxide synthesis inhibition. Hypertension 1996; 27(3 Pt 2):613-618.
107. DiBona GF, Herman PJ, Sawin LL. Neural control of renal function in edemaform-ing states. Am J Physiol 1988; 254(6 Pt 2):R1017-1024.
108. Cohn JN. Plasma norepinephrine and mortality. Clin Cardiol 1995; 18(suppl 1):19-12.
109. Kirchheim HR. Systemic arterial baroreceptor reflexes. Physiol Rev 1976; 56:100-177.
110. Esler M, Jennings G, Lambert G, Meredith I, Home M, Eisenhofer G. Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol Rev 1990; 70:963-985.
111. Hasking GJ, Esler MD, Jennings GL, Burton D, Johns JA, Korner PI. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 1986; 73:615-621.
112. Willett I, Esler M, Burke F, Leonard P, Dudley F. Total and renal sympathetic nervous system activity in alcoholic cirrhosis. J Hepatol 1985; 1:639-648.
113. Tulassay T, Rascher W, Lang RE, Seyberth HW, Scharer K. Atrial natriuretic peptide and other vasoactive hormones in nephrotic syndrome. Kidney Int 1987; 31:1391-1395.
114. Kelsch RC, Light GS, Oliver WJ. The effect of albumin infusion upon plasma norepinephrine concentration in nephrotic children. J Lab Clin Med 1972; 79:516-525.
115. Rahman SN, Abraham WT, Van Putten VJ, Hasbargen JA, Schrier RW. Increased norepinephrine secretion in patients with the nephrotic syndrome and normal glomerular filtration rates: evidence for primary sympathetic activation. Am J Nephrol 1993; 13:266-270.
116. Solis-Herruzo JA, Duran A, Favela V, Castellano G, Madrid JL, Munoz-Yague MT, Morillas JD, Estenoz J. Effects of lumbar sympathetic block on kidney function in cirrhotic patients with hepatorenal syndrome. J Hepatol 1987; 5:167-173.
117. DiBona GF, Sawin LL. Role of renal nerves in sodium retention of cirrhosis and congestive heart failure. Am J Physiol 1991; 260(2 Pt 2):R298-305.
118. Morita H, Matsuda T, Tanaka K, Hosomi H. Role of hepatic receptors in controlling body fluid homeostasis. Jpn J Physiol 1995; 45:355-368.
119. Perin PC, Maule S, Quadri R. Sympathetic nervous system, diabetes, and hypertension. Clin Exp Hypertens 2001; 23:45-55.
120. Schobel HP, Fischer T, Heuszer K, Geiger H, Schmieder RE. Preeclampsia—a state of sympathetic overactivity. N Engl J Med 1996; 14:1480-1485.
121. Baehler RW, Williams RH, Work J, Gottschall J, Chuang V. Studies on the natural history of the norepinephrine model of acute renal failure in the dog. Nephron 1980; 26(6):266-273.
122. Schafferhans K, Heidbreder E, Grimm D, Heidland A. Norepinephrine-induced acute renal failure: beneficial effects of atrial natriuretic factor. Nephron 1986; 44:240-244.
123. Kulka PJ, Tryba M, Zenz M. Preoperative alpha2-adrenergic receptor agonists prevent the deterioration of renal function after cardiac surgery: results of a randomized, controlled trial. Crit Care Med 1996; 24:947-952.
124. Converse RL Jr, Jacobsen TN, Toto RD, Jost CM, Cosentino F, Fouad-Tarazi F, Victor RG. Sympathetic overactivity in patients with chronic renal failure. N Engl J Med 1992; 327:1912-1918.
125. Ye S, Ozgur B, Campese VM. Renal afferent impulses, the posterior hypothalamus and hypertension in rats with chronic renal failure. Kidney Int 1997; 51:722-727.
126. Bigazzi R, Kogosov E, Campese VM. Altered norepinephrine turnover in the brain of rats with chronic renal failure. J Am Soc Nephrol 1994; 4:1901-1907.
127. Bigazzi R, Kogosov E, Campese VM. Altered norepinephrine turnover in the brown fat of rats with chronic renal failure. J Am Soc Nephrol 1994; 4:1896-1900.
128. Ye S, Mozayeni P, Gamburd M, Zhong H, Campese VM. Interleukin-1 beta and neurogenic control of blood pressure in normal rats and rats with chronic renal failure. Am J Physiol Heart Circ Physiol 2000; 279:H2786-2796.
129. Ye S, Nosrati S, Campese VM. Nitric oxide (NO) modulates the neurogenic control of blood pressure in rats with chronic renal failure (CRF). J Clin Invest 1997; 99:540-548.
130. Sakuma I, Togashi H, Yoshioka M, Saito H, Yanagida M, Tamura M, Kobayashi T, Yasuda H, Gross SS, Levi R. NG-methyl-L-arginine, an inhibitor of L-arginine-de-rived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. A role for nitric oxide in the central regulation of sympathetic tone? Circ Res 1992; 70:607-611.
131. Hansen J, Jacobsen TN, Victor RG. Is nitric oxide involved in the tonic inhibition of central sympathetic outflow in humans? Hypertension. 1994; 24:439-444.
132. Ligtenberg G, Blankestijn PJ, Oey PL, Klein IH, Dijkhorst-Oei LT, Boomsma F, Wieneke GH, van Huffelen AC, Koomans HA. Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure. N Engl J Med 1999; 340:1321-1328.
133. Cerasola G, Vecchi M, Mule G, Cottone S, Mangano MT, Andronico G, Contorno A, Parrino I, Renda F, Pavone G. Sympathetic activity and blood pressure pattern in autosomal dominant polycystic kidney disease hypertensives. Am J Nephrol 1998; 18:391-398.
134. Hausberg M, Kosch M, Barenbrock M, Hohage H, Kisters K, Rahn KH. Influence of remnant kidneys on muscle sympathetic nerve activity in renal allograft recipients. Kidney Blood Press Res 2000; 23:298-299.
135. Wu W, Zhang Y, Ballew JR, Fink G, Wang DH. Development of hypertension induced by subpressor infusion of angiotensin II: role of sensory nerves. Hypertension 2000; 36:549-552.
136. Zeier M, Fehrenbach P, Geberth S, Mohring K, Waldherr R, Ritz E. Renal histology in polycystic kidney disease with incipient and advanced renal failure. Kidney Int 1992; 42:1259-1265.
137. Torres VE, Donovan KA, Scicli G, Holley KE, Thibodeau SN, Carretero OA, Inagami T, McAteer JA, Johnson CM. Synthesis of renin by tubulocystic epithelium in autosomal-dominant polycystic kidney disease. Kidney Int 1992; 42:364-373.
138. Gilbert RE, Wu LL, Kelly DJ, Cox A, Wilkinson-Berka JL, Johnston CI, Cooper ME. Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy. Implications for the pathogenesis of tubulointerstitial fibrosis. Am J Pathol 1999; 155:429-440.
139. Stenvinkel P. Leptin and its clinical implications in chronic renal failure. Miner Electrolyte Metab 1999; 25:298-302.
140. Takekoshi K, Motooka M, Isobe K, Nomura F, Manmoku T, Ishii K, Nakai T. Lep-tin directly stimulates catecholamine secretion and synthesis in cultured porcine adrenal medullary chromaffin cells. Biochem Biophys Res Commun 1999; 261:426-431.
141. Amann K, Rump LC, Simonaviciene A, Oberhauser V, Wessels S, Orth SR, Gross ML, Koch A, Bielenberg GW, Van Kats JP, Ehmke H, Mall G, Ritz E. Effects of low dose sympathetic inhibition on glomerulosclerosis and albuminuria in subto-tally nephrectomized rats. J Am Soc Nephrol 2000; 11:1469-1478.
142. Bohmann C, Schollmeyer P, Rump LC. Effects of imidazolines on noradrenaline release in rat isolated kidney. Naunyn Schmiedebergs Arch Pharmacol 1994; 349:118-124.
143. Amann K, Koch A, Hofstetter J, Gross ML, Haas C, Orth SR, Ehmke H, Rump LC, Ritz E. Glomerulosclerosis and progression—the effect of subantihypertensive doses of a- and ß-blockers. Kidney Int 2001; 60:1309-1323.
144. Odoni G, Ogata H, Oberhauser V, Amann K, Rump LC, Ritz E, Orth SR Renal denervation in subtotally nephrectomized (SNX)-rats attenuates structural renal damage. Hypertension 2000; 36:670 (PG.02).
145. Strojek K, Grzeszczak W, Gorska J, Leschinger MI, Ritz E. Lowering of microalbuminuria in diabetic patients by a sympathicoplegic agent: novel approach to prevent progression of diabetic nephropathy? J Am Soc Nephrol 2001; 12:602-605.
146. Garcia-Sainz JA, Vazquez-Prado J, Villalobos-Molina R. Alpha 1-adrenoceptors: subtypes, signaling, and roles in health and disease. Arch Med Res 1999; 30:449-458.
147. Huber TB, Gloy J, Henger A, Schollmeyer P, Greger R, Mundel P, Pavenstädt H. Catecholamines modulate podocyte function. J Am Soc Nephrol 1998; 9:335-345.
148. Norman JT, Clark IM, Garcia PL. Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int 2000; 58:2351-2366.